Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
基本信息
- 批准号:9796511
- 负责人:
- 金额:$ 50.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:BindingCRISPR/Cas technologyCardiacCardiac MyocytesCardiac developmentCardiovascular systemCell NucleusCellsChIP-seqComplexCongenital Heart DefectsCytoplasmDevelopmentDrosophila genusElectrophysiology (science)Epigenetic ProcessExhibitsGene ExpressionGenesGeneticGenetic TranscriptionHeartHeterogeneityHumanKnock-outLaboratoriesMediatingMesodermMessenger RNAMicroRNAsModificationMolecularMorphogenesisMusNamesNuclearOrganogenesisOutcomePathogenicityPathway interactionsPlayPluripotent Stem CellsPolycombPropertyProteinsRecording of previous eventsRegulator GenesRoleSignal TransductionStem Cell ResearchStretchingTestingTissuesTranscriptUntranslated RNAXenopuscardiogenesiscell fate specificationhistone modificationhuman pluripotent stem cellhuman stem cellsinduced pluripotent stem cellknock-downnoveloverexpressionpluripotencyprogenitorprogramspromotersingle-cell RNA sequencingtranscription factortranscriptome
项目摘要
PROJECT SUMMARY/ABSTRACT
During the past decades, studies of heart development have been mainly focused on conserved gene
regulatory mechanisms, which control various aspects of cardiogenesis across multiple species from
drosophila to mouse. These conserved gene programs include cardiac transcriptional factors (such as Nkx2.5,
Isl1, Tbx20), microRNAs, and epigenetic regulators. Despite the high evolutionary conservation of
cardiogenesis, the human heart exhibits unique properties, including distinctive morphogenesis and
electrophysiological properties. These species-specific differences suggest the existence of novel genetic
programs in each species. As the limitation of experimental setting, it remains unclear the mechanisms that
regulate unique aspects of human cardiogenesis, and how human-specific mechanisms interact with
conserved gene programs to fine-tune human heart development. Recently, accumulating evidence
demonstrated that long noncoding RNAs (lncRNAs) play important roles in cell fate specification and
organogenesis, including the heart. LncRNAs are greater than 200bp non-coding transcripts, which account for
>40% of human transcriptome. Many lncRNAs are tissue-specific and species-specific. Recently, we identified
a novel human-specific lncRNA, named Heart Brake LncRNA1 (HBL1) (Dev. Cell. 2017, 4:333-8). HBL1 is
highly expressed in both cytoplasm and nucleus of human induced pluripotent stem cells (hiPSCs). Cytosolic
HBL1 modulates cardiomyocyte (CM) development from hiPSCs by counteracting microRNA1 (MIR1).
Pluripotency marker gene SOX2 activates HBL1 transcription. In this proposal, we will analyze further, a novel
mechanism of nuclear HBL1 in initiating the cardiac gene-expressing program via interacting with polycomb
repressive complex 2 (PRC2). Additionally, we will test a hypothesis that HBL1 adds a new layer of human-
specific regulatory mechanism on top of a conserved cardiogenic axis. All together, the central hypothesis is
that transcriptional factor SOX2, lncRNA HBL1, microRNA-1 and PRC2 complex composite a whole network to
control human cardiogenesis from pluripotent stem cells.
项目摘要/摘要
在过去的几十年中,心脏发育的研究主要集中在保守的基因上
调节机制,控制着多种物种的心脏病的各个方面
果蝇到小鼠。这些保守的基因程序包括心脏转录因子(例如NKX2.5,
ISL1,TBX20),microRNA和表观遗传调节剂。尽管有很高的进化保护
心脏病发生,人类心脏表现出独特的特性,包括独特的形态发生和
电生理特性。这些特定物种的差异表明存在新遗传
每个物种的程序。作为实验环境的局限性,尚不清楚
调节人类心脏病的独特方面,以及人类特异性机制如何与
保守的基因程序,以微调人类心脏的发展。最近,积累了证据
证明长的非编码RNA(LNCRNA)在细胞命运规范和
器官发生,包括心脏。 LNCRNA大于200bp的非编码成绩单,该笔录的解释为
> 40%的人类转录组。许多LNCRNA是组织特异性和物种特异性的。最近,我们确定了
一种新型的人类特异性LNCRNA,名为Heart Brake LncRNA1(HBL1)(Dev。Cell。2017,4:333-8)。 HBL1是
在人类诱导的多能干细胞(HIPSC)的细胞质和核中高度表达。胞质
HBL1通过抵消MicroRNA1(miR1)调节HIPSC的心肌细胞(CM)发育。
多能标记基因SOX2激活HBL1转录。在此提案中,我们将进一步分析一本小说
核HBL1的机理在启动心脏基因表达程序中通过与PolyComb相互作用
抑制性复合物2(PRC2)。此外,我们将检验一个假设,即HBL1添加了一层新的人类
保守的心源轴之上的特定调节机制。总之,中心假设是
转录因子SOX2,LNCRNA HBL1,microRNA-1和PRC2复合复合材料整个网络
从多能干细胞中控制人的心脏病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lei Yang其他文献
Lei Yang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lei Yang', 18)}}的其他基金
Deciphering a Novel LncRNA-mediated Lipid Droplet Transport System in Human Heart
破译人类心脏中新型 LncRNA 介导的脂滴转运系统
- 批准号:
10640148 - 财政年份:2022
- 资助金额:
$ 50.2万 - 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
- 批准号:
10242624 - 财政年份:2019
- 资助金额:
$ 50.2万 - 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
- 批准号:
10463693 - 财政年份:2019
- 资助金额:
$ 50.2万 - 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
- 批准号:
10688201 - 财政年份:2019
- 资助金额:
$ 50.2万 - 项目类别:
Embryonic stem cell/induced Pluripotent stem cell growth and gene editing core
胚胎干细胞/诱导多能干细胞生长和基因编辑核心
- 批准号:
10495947 - 财政年份:2017
- 资助金额:
$ 50.2万 - 项目类别:
Toward Regeneration of Whole Bioartificial Human Heart
走向整个生物人工心脏的再生
- 批准号:
8749862 - 财政年份:2014
- 资助金额:
$ 50.2万 - 项目类别:
相似国自然基金
基于CRISPR-Cas3系统靶向消减宿主背景的病原体高通量测序技术研究
- 批准号:32300080
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于柔性电极微电场的视网膜基因电转技术及其在CRISPR/Cas9基因编辑治疗遗传性视网膜疾病中的作用研究
- 批准号:82371075
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
结合CRISPR/Cas9技术调控肿瘤代谢重编程与氧化还原稳态的仿生纳米载药系统的构建及其HNSCC精准治疗研究
- 批准号:82304425
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于核酸预富集和CRISPR-Cas13a技术的新型梅毒核酸诊断和即时检测研究
- 批准号:82302579
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于CRISPR/Cas9-NHEJ基因编辑技术的致病型问号钩体跨人血管内皮层转运机制研究
- 批准号:82302545
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining the developmental mechanisms of pericardium formation
定义心包形成的发育机制
- 批准号:
10605059 - 财政年份:2023
- 资助金额:
$ 50.2万 - 项目类别:
Arrestin domain-containing protein 4 as a novel regulator of glucose metabolism in the ischemic heart
含 Arrestin 结构域的蛋白 4 作为缺血心脏葡萄糖代谢的新型调节剂
- 批准号:
10735139 - 财政年份:2023
- 资助金额:
$ 50.2万 - 项目类别:
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
锌可预防心脏缺血再灌注损伤
- 批准号:
10652915 - 财政年份:2023
- 资助金额:
$ 50.2万 - 项目类别:
Targeting the Calcitonin-BMP1 Pathway in Atrial Cardiofibroblasts to Ameliorate Atrial Fibrillation
靶向心房心成纤维细胞中的降钙素-BMP1 通路以改善心房颤动
- 批准号:
10750270 - 财政年份:2023
- 资助金额:
$ 50.2万 - 项目类别:
Optimization of a carbon monoxide (CO) sensing hemoprotein for applications as an antidote for CO poisoning and a biosensor for CO detection in living cells
优化一氧化碳 (CO) 传感血红蛋白作为 CO 中毒解毒剂的应用和用于活细胞中 CO 检测的生物传感器
- 批准号:
10643257 - 财政年份:2023
- 资助金额:
$ 50.2万 - 项目类别: